Blues’ Colton Parayko Out Six Weeks After Knee Operation

In a massive blow to their defensive core, the St. Louis Blues announced Colton Parayko will miss the next six weeks after undergoing a scope on his left knee. Given that six weeks from today is two days after the Blues’ final regular season matchup, it likely means Parayko is done for the regular season.

The knee procedure was required after the team’s shootout win against the Los Angeles Kings last night. During the overtime period, Parayko fell awkwardly after an offensive zone faceoff, leading to his removal from the game for the remainder of the action.

It’s an unfortunate end to what was becoming a career year for the St. Albert, Alberta native. Parayko was, and still is, leading all Blues defensemen in goals, assists, points, even-strength goals, shots on goal, average time on ice, blocked shots, hits, and takeaways. He had already matched his career-high of 35 points in 18 fewer games.

Still, it wasn’t a completely perfect season for Parayko. Although his possession metrics have improved from last year, he’s still averaging a 47.1% CorsiFor% at even strength, slightly below his career average of 48.3%. Meanwhile, his defensive metrics have taken a hit, as evidenced by his career low 89.8% on-ice save percentage at even strength, but much of that can be explained by his 59.0% defensive zone starts percentage.

Regardless of the moderately depressed defensive metrics, it’s hard to define Parayko’s 2024-25 campaign as anything short of an impressive rebound. He’s raised his On-Ice Goals % at even strength from 40.7% in 2022-23 and 46.2% in 2023-24 to a solid 53.2% in 2024-25, notably driving the Blues’ offense.

After appearing as a net loss contract a few years ago, Parayko’s $6.5MM salary through the 2029-30 season is becoming more of an ideal contract for St. Louis. Parayko had been floated as a potential trade candidate leading into Friday’s deadline, but interested teams will likely revisit in the offseason once he’s recovered from the knee injury.